Join or renew today
Deborah L. Shelton and Jason Grotto of the Chicago Tribune couldn't help but wonder: How does a medical device get implanted into patients without first getting FDA approval?
That question led to their two-day series in late May that reported for the first time that certain heart valve repair devices had been "down-classed" from class III to class II, a regulatory category that required that they undergo less scrutiny, even though the devices are permanently implanted and life-sustaining.
One of the annuloplasty rings had been stitched into the hearts of at least 700 patients in Chicago and elsewhere without going through proper channels. In fact, even though the company could have submitted both rings for clearance through a less rigorous regulatory pathway, it didn't even do that. In these two cases, the process was skipped in its entirety.
The page you have requested is available to AHCJ members only. If you are
a member, please login below.
If you're not a member, we invite you to join us. Read about member
benefits and how to join.
Please provide your user ID and password below:
~ or ~
Log in by email, using your email address: